Max Robotics — Global Service Robot Directory + US Certification

About

Matthew J. Resnick is a urologic surgeon and health services researcher whose work bridges surgical innovation and population-level outcomes. His research focuses on prostate cancer treatment, robotic surgery, and the comparative effectiveness of surgical approaches. Resnick’s major contributions include critically evaluating the real-world harms of robotic versus open prostatectomy, challenging assumptions about the superiority of minimally invasive techniques. His landmark 2015 study, with 64 citations, used population-based data to reveal that robotic prostatectomy offered no clear advantage over open surgery in disease control or functional outcomes, while carrying distinct risks. Earlier, he advanced pediatric urology with a 2008 paper on robotic ureterocalicostomy (67 citations), demonstrating technical feasibility in complex ureteropelvic junction obstruction cases. Resnick’s work is notable for its methodological rigor, using large cohorts to inform evidence-based surgical decision-making. His research has shaped clinical guidelines and sparked debate on the adoption of new technologies. For students and researchers, Resnick exemplifies how combining clinical expertise with health services research can expose hidden trade-offs in surgical care, emphasizing the need for data-driven practice over technological hype.